PL374869A1 - Sposób diagnozowania stwardnienia rozsianego - Google Patents

Sposób diagnozowania stwardnienia rozsianego

Info

Publication number
PL374869A1
PL374869A1 PL03374869A PL37486903A PL374869A1 PL 374869 A1 PL374869 A1 PL 374869A1 PL 03374869 A PL03374869 A PL 03374869A PL 37486903 A PL37486903 A PL 37486903A PL 374869 A1 PL374869 A1 PL 374869A1
Authority
PL
Poland
Prior art keywords
multiple sclerosis
diagnosing multiple
diagnosing
glycans
antibodies
Prior art date
Application number
PL03374869A
Other languages
English (en)
Other versions
PL210512B1 (pl
Inventor
Nir Dotan
Avinoam Dukler
Mikael Schwarz
Ari Gargir
Original Assignee
Glycominds Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycominds Ltd. filed Critical Glycominds Ltd.
Publication of PL374869A1 publication Critical patent/PL374869A1/pl
Publication of PL210512B1 publication Critical patent/PL210512B1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Testing Of Engines (AREA)
  • Heat Treatment Of Steel (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL374869A 2002-08-02 2003-08-04 Sposób, zestaw i podłoże do diagnozowania stwardnienia rozsianego PL210512B1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40091402P 2002-08-02 2002-08-02
US44707603P 2003-02-13 2003-02-13
US46298403P 2003-04-15 2003-04-15
US47323103P 2003-05-23 2003-05-23

Publications (2)

Publication Number Publication Date
PL374869A1 true PL374869A1 (pl) 2005-11-14
PL210512B1 PL210512B1 (pl) 2012-01-31

Family

ID=31721743

Family Applications (1)

Application Number Title Priority Date Filing Date
PL374869A PL210512B1 (pl) 2002-08-02 2003-08-04 Sposób, zestaw i podłoże do diagnozowania stwardnienia rozsianego

Country Status (18)

Country Link
US (2) US7537900B2 (pl)
EP (1) EP1529216B1 (pl)
JP (2) JP4721703B2 (pl)
AT (1) ATE376672T1 (pl)
AU (1) AU2003263409B2 (pl)
BR (1) BR0313194A (pl)
CA (1) CA2494422A1 (pl)
CY (1) CY1107859T1 (pl)
DE (1) DE60317070T2 (pl)
DK (1) DK1529216T3 (pl)
ES (1) ES2297248T3 (pl)
IL (1) IL166539A (pl)
MX (1) MXPA05001270A (pl)
NO (1) NO20051024L (pl)
NZ (1) NZ585114A (pl)
PL (1) PL210512B1 (pl)
PT (1) PT1529216E (pl)
WO (1) WO2004015420A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1529216T3 (da) * 2002-08-02 2008-02-25 Glycominds Ltd Fremgangsmåde til diagnosticering af dissemineret sklerose
US7592150B2 (en) 2003-12-03 2009-09-22 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
EP1692519B1 (en) * 2003-12-03 2010-06-02 Glycominds Ltd. Method for diagnosing diseases based on levels of anti-glycan antibodies
EP1771733A2 (en) * 2004-06-24 2007-04-11 The Scripps Research Institute Arrays with cleavable linkers
US8216791B2 (en) 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
DK1929297T3 (da) * 2005-09-29 2013-03-04 Caprion Proteomics Usa Llc Biomarkører for dissemineret sklerose og fremgangsmåder til anvendelse heraf
US20100203569A1 (en) 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
WO2011031472A2 (en) * 2009-08-25 2011-03-17 The Johns Hopkins University Detection of auto-antibodies to specific glycans as diagnostic tests for autoimmune diseases
US9994605B2 (en) 2014-03-13 2018-06-12 Universitaet Basel Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein
WO2016026143A1 (en) * 2014-08-22 2016-02-25 Huiru Wang Saccharide-based biomarkers and therapeutics
US10495646B2 (en) 2015-01-30 2019-12-03 The Regents Of The University Of California N-acetyl glucosamine as a biomarker of MS disease course
CA2996073A1 (en) 2015-09-16 2017-03-23 Universitat Basel Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids
EP4521117A3 (en) * 2016-07-01 2025-06-04 Dignity Health Diagnostic or predictor of relapsing remitting multiple sclerosis
JP2021520493A (ja) * 2018-04-03 2021-08-19 クリエイティクス エルエルシー 胃腸洗浄液試料における免疫グロブリンのグリカン結合パターンを評価するがん検出方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5030560A (en) * 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
JPH02161357A (ja) * 1988-12-15 1990-06-21 Tosoh Corp 免疫測定用材料の安定化方法
AU776632B2 (en) 1999-02-17 2004-09-16 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US20010051349A1 (en) 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
KR20020089323A (ko) * 2000-01-10 2002-11-29 제노스펙트라 인코포레이티드 선형 프로브 캐리어
WO2002018950A1 (en) 2000-08-28 2002-03-07 The Trustees Of Columbia University In The City Of New York Detection of anti-glycolipid antibodies by latex agglutination assay
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
DK1529216T3 (da) * 2002-08-02 2008-02-25 Glycominds Ltd Fremgangsmåde til diagnosticering af dissemineret sklerose
US20040241763A1 (en) * 2002-08-02 2004-12-02 Nir Dotan Method for diagnosing multiple sclerosis
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis

Also Published As

Publication number Publication date
JP4721703B2 (ja) 2011-07-13
US20040077023A1 (en) 2004-04-22
US7537900B2 (en) 2009-05-26
WO2004015420A1 (en) 2004-02-19
AU2003263409A1 (en) 2004-02-25
MXPA05001270A (es) 2005-08-03
IL166539A0 (en) 2006-01-15
US20100081160A1 (en) 2010-04-01
EP1529216B1 (en) 2007-10-24
JP2006501441A (ja) 2006-01-12
NZ585114A (en) 2011-09-30
CA2494422A1 (en) 2004-02-19
EP1529216A1 (en) 2005-05-11
NO20051024L (no) 2005-05-02
PT1529216E (pt) 2008-01-30
CY1107859T1 (el) 2013-06-19
ES2297248T3 (es) 2008-05-01
JP2009258138A (ja) 2009-11-05
DE60317070D1 (de) 2007-12-06
ATE376672T1 (de) 2007-11-15
DK1529216T3 (da) 2008-02-25
DE60317070T2 (de) 2008-07-24
BR0313194A (pt) 2005-07-12
WO2004015420A8 (en) 2004-09-10
AU2003263409B2 (en) 2010-05-27
IL166539A (en) 2010-11-30
PL210512B1 (pl) 2012-01-31
WO2004015420B1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
CY1107859T1 (el) Μεθοδος για διαγνωση πολλαπλης σκληρυνσης
WO2006117689A3 (en) Method for diagnosing multiple sclerosis
AU2003298878A1 (en) Sample substrate for use in biological testing and method for filling a sample substrate
WO2003060653A3 (en) Method and/or system for analyzing biological samples using a computer system
AU2002348289A8 (en) Method of using a non-antibody protein to detect and measure an analyte
GB2457856A (en) Cement bond analysis
EP1525534A4 (en) SITE ANALYSIS SYSTEM WITH CENTRAL PROCESSOR AND METHOD OF ANALYSIS
DE60228557D1 (de) Candida-nachweis
AU2003278768A1 (en) Method and system for assessment of biomarkers by measurement of response to stimulus
EP1102988B8 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
AU2003257001A1 (en) A method of sample preparation for atom probes and source of specimens
MXPA02009476A (es) Sistema y metodo para analisis de sensibilidad de transision de modelo.
AU2002233800A1 (en) Method and kit for predicting cancer
AU2003234787A1 (en) Instrument and method for measuring action signal of biological sample
DE602005024254D1 (pl)
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
IL171913A0 (en) Method of chromatographic analysis of a protein solution
GB0221216D0 (en) Method of measuring exhaust flow constituents
ATE526582T1 (de) Generisches verfahren für latex- agglutinationstests
MXPA02005109A (es) Metodo para calibrar un analizador de muestras.
EP1636587A4 (en) DIAGNOSTIC KIT FOR LIVER CIRRHOSIS COMPRISING A SPECIFIC ANTIBODY OF A HUMAN PROTO-ONCOGEN PROTEIN
GB0317304D0 (en) An analysis apparatus arranged to analyse data and detect change and related methods
AU2002357820A8 (en) Diagnostic methods for protein profiling
EP1801231A4 (en) METHOD OF SCREENING THE BAFF SUPPRESSOR OR INHIBITOR
AU3986697A (en) Use of molt4 cd69 expression to determine the presence and activity of interferon inhibitors

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140804